A detailed history of Nebula Research & Development LLC transactions in Quanterix Corp stock. As of the latest transaction made, Nebula Research & Development LLC holds 38,377 shares of QTRX stock, worth $452,081. This represents 0.06% of its overall portfolio holdings.

Number of Shares
38,377
Previous 33,666 13.99%
Holding current value
$452,081
Previous $445 Million 11.84%
% of portfolio
0.06%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.92 - $16.36 $51,444 - $77,071
4,711 Added 13.99%
38,377 $497 Million
Q2 2024

Aug 14, 2024

BUY
$12.26 - $23.78 $235,943 - $457,646
19,245 Added 133.45%
33,666 $445 Million
Q1 2024

May 15, 2024

BUY
$21.9 - $28.28 $133,130 - $171,914
6,079 Added 72.87%
14,421 $340 Million
Q4 2023

Feb 14, 2024

BUY
$19.54 - $28.66 $163,002 - $239,081
8,342 New
8,342 $228 Million

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $436M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.